Browsing Tag
Click Therapeutics
1 post
Click Therapeutics faces reimbursement test as Motivista opens new schizophrenia treatment market
Motivista wins FDA clearance for schizophrenia negative symptoms as Click Therapeutics turns to payer coverage, adoption and commercial launch.